Using pathway analysis to compare CBF and non-CBF AML proteomic profiles revealed involvement in hematopoietic cell lineage development, platelet activation/signaling/aggregation, and endothelial cell proliferation. The gene discussed is CEBPZ; the disease is acute myeloid leukemia.